Universal mRNA Vaccine Eradicates Tumors in Mice nd Advances Toward Human Trials
ALACHUA COUNTY, FLORIDA, JUL 18 – Researchers at the University of Florida aim to create an off-the-shelf cancer vaccine that activates immune responses like viral infections, with some mouse models showing complete tumor elimination.
- Last year, University of Florida researchers developed an experimental mRNA cancer vaccine, uniquely stimulating immune responses as if fighting a virus.
- Prior work in mRNA technology led to the development of an experimental vaccine that stimulates immune responses, explaining the scientific rationale.
- Animal studies revealed that in mouse models, the vaccine triggered a strong anticancer response, with some tumors completely eradicated, even without targeting specific cancer types.
- Sayour noted the vaccine's broad potential as an alternative to surgery, radiation, and chemotherapy, highlighting its implications for treatment-resistant tumors.
- Next steps include refining the vaccine formulations and moving toward human clinical trials, bringing us closer to a universal cancer vaccine with broad therapeutic potential.
29 Articles
29 Articles


A new vaccine could pave the way for universal cancer vaccinations that "incite" the immune system against tumours in affected patients
An experimental ARN messageer-based vaccine (ARNm) has broadened the effects of immunotherapy tumors in a study conducted on rats, bringing researchers closer to their goal: developing a universal vaccine to...
New mRNA vaccine strategy awakens immune system to fight cancer
An experimental mRNA vaccine boosted the tumor-fighting effects of immunotherapy in a mouse-model study, bringing researchers one step closer to their goal of developing a universal vaccine to "wake up" the immune system against cancer.
Coverage Details
Bias Distribution
- 60% of the sources are Center
To view factuality data please Upgrade to Premium